← Back to Search

Other

ICP-332 for Healthy Volunteers

Phase 1
Recruiting
Research Sponsored by InnoCare Pharma Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Male or infertile female subjects who are between 18-55 years old (inclusive)
Be between 18 and 65 years old
Must not have
History of tuberculosis or current active/latent infection
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights

Summary

This trial is testing different doses of ICP-332 in healthy volunteers to see how the drug behaves in the body when given multiple times.

Who is the study for?
This trial is for healthy individuals who meet specific health criteria. The exact inclusion and exclusion details are not provided, but typically participants should have no significant medical conditions and be within a certain age range.
What is being tested?
The study is testing ICP-332 tablets against placebo tablets to see how they're tolerated in the body and what effects they have. It's a phase I trial, which means it's an early-stage study focusing on safety.
What are the potential side effects?
Since this is a phase I trial of ICP-332 in healthy subjects, potential side effects are unknown at this stage. They will be closely monitored for any adverse reactions compared to those taking the placebo.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am a man or a woman unable to have children, aged 18 to 55.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have had tuberculosis or currently have an active or latent infection.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: ICP-332Experimental Treatment1 Intervention
Group II: PlaceboPlacebo Group1 Intervention

Find a Location

Logistics

Participation is compensated

You will be compensated for participating in this trial.

Who is running the clinical trial?

InnoCare Pharma Inc.Lead Sponsor
4 Previous Clinical Trials
600 Total Patients Enrolled
~14 spots leftby Dec 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top